{"transactions":[{"id":1878035,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":113126,"kind":"person","name":"Honig Peter","position":1,"cik":"0001484780","reported_name":"Honig Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2023-05-25T16:06:10.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 100% of the underlying shares on May 24, 2024."}],"balance_after":34000,"derivative":{"exercise_price":2.5,"expiration_date":"2033-05-23","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001209191-23-032140","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484780/000120919123032140/doc4.xml","form_type":"4"}},{"id":2222020,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":113126,"kind":"person","name":"Honig Peter","position":1,"cik":"0001484780","reported_name":"Honig Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-06-24T18:31:43.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on June 22, 2022 and vests over one year, with 1/12th of the shares subject to the option vesting at the end of each successive one-month period following the grant date until the earlier of a) the day that is one business day prior to the date of the next annual meeting and b) the first anniversary of the grant date, at which time such option shall be fully vested."}],"balance_after":65000,"derivative":{"exercise_price":0.79,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001485003-22-000084","document":"wf-form4_165610988351357.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000148500322000084/wf-form4_165610988351357.xml","form_type":"4"}},{"id":2222019,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":113126,"kind":"person","name":"Honig Peter","position":1,"cik":"0001484780","reported_name":"Honig Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-24T18:31:43.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") which shall vest on the first anniversary of the grant date. Each RSU represents a contingent right to receive one share of Sesen Bio, Inc. common stock."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001485003-22-000084","document":"wf-form4_165610988351357.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000148500322000084/wf-form4_165610988351357.xml","form_type":"4"}},{"id":2261784,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":113126,"kind":"person","name":"Honig Peter","position":1,"cik":"0001484780","reported_name":"Honig Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2022-05-20T16:06:43.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":10995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 100% of the underlying shares on the earlier of May 19, 2023 or the next annual meeting of stockholders of Karyopharm Therapeutics Inc."}],"balance_after":10995,"derivative":{"exercise_price":5.65,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":10995},"source":{"system":"sec-edgar","filing":"0001209191-22-030970","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484780/000120919122030970/doc4.xml","form_type":"4"}},{"id":2482176,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":113126,"kind":"person","name":"Honig Peter","position":1,"cik":"0001484780","reported_name":"Honig Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2021-12-07T10:37:46.000Z","date":"2021-12-03","kind":"grant","acquired":true,"shares":47800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on December 3, 2021.  The shares underlying the option vest as to one-third (1/3) of the shares on December 3, 2022 and as to the remaining two-thirds (2/3) of the shares in 24 equal monthly installments thereafter."}],"balance_after":47800,"derivative":{"exercise_price":6.72,"expiration_date":"2031-12-02","underlying":"Common Stock","underlying_shares":47800},"source":{"system":"sec-edgar","filing":"0001209191-21-068261","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484780/000120919121068261/doc4.xml","form_type":"4"}},{"id":2628152,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":113126,"kind":"person","name":"Honig Peter","position":1,"cik":"0001484780","reported_name":"Honig Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-07-21T17:37:17.000Z","date":"2021-07-20","kind":"grant","acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on July 20, 2021 and vests monthly in equal amounts over a three-year period following the grant date. Based on market analysis by Radford of public, pre-commercial biopharmaceutical companies with less than 200 employees and market values between $250 million and $1 billion, the compensation committee of Sesen Bio, Inc. (the \"Company\") recommended to the Company's board of directors, and the board of directors approved, the amount of the initial grant to the reporting person in connection with the reporting person's appointment as a non-employee director."}],"balance_after":185000,"derivative":{"exercise_price":3.86,"expiration_date":"2031-07-20","underlying":"Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001485003-21-000158","document":"wf-form4_162690342009283.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000148500321000158/wf-form4_162690342009283.xml","form_type":"4"}},{"id":4255288,"issuer":{"id":157016,"kind":"organization","name":"Orexigen Therapeutics, Inc.","symbol":"OREXQ"},"owners":[{"id":113126,"kind":"person","name":"Honig Peter","position":1,"cik":"0001484780","reported_name":"Honig Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-18T19:38:38.000Z","date":"2017-07-14","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the original number of shares of stock subject to the option (rounded down to the next whole number of shares) shall vest in equal monthly installments over 12 months following the vesting commencement date of July 14, 2017, subject to the Reporting Person's continuing service on the Issuer's Board of Directors through each such date, and subject to the terms of the Stock Option Agreement in the event of a change in control of the Issuer."}],"balance_after":5000,"derivative":{"exercise_price":2.88,"expiration_date":"2027-07-13","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-17-045599","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484780/000120919117045599/doc4.xml","form_type":"4"}}]}